These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 36922934)

  • 21. Synergistic anti-pancreatic cancer immunological effects by treatment with reduced expression in immortalized cells/dickkopf-3 protein and peripheral blood mononuclear cells.
    Uchida D; Shiraha H; Kato H; Sawahara H; Nagahara T; Iwamuro M; Kataoka J; Horiguchi S; Watanabe M; Takaki A; Nouso K; Nasu Y; Kumon H; Yamamoto K
    J Gastroenterol Hepatol; 2016 Jun; 31(6):1154-9. PubMed ID: 26643412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Manipulating the Wnt/β-catenin signaling pathway to promote anti-tumor immune infiltration into the TME to sensitize ovarian cancer to ICB therapy.
    Wall JA; Meza-Perez S; Scalise CB; Katre A; Londoño AI; Turbitt WJ; Randall T; Norian LA; Arend RC
    Gynecol Oncol; 2021 Jan; 160(1):285-294. PubMed ID: 33168307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. R-spondin-3 promotes proliferation and invasion of breast cancer cells independently of Wnt signaling.
    Ter Steege EJ; Doornbos LW; Haughton PD; van Diest PJ; Hilkens J; Derksen PWB; Bakker ERM
    Cancer Lett; 2023 Aug; 568():216301. PubMed ID: 37406727
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for tankyrases as antineoplastic targets in lung cancer.
    Busch AM; Johnson KC; Stan RV; Sanglikar A; Ahmed Y; Dmitrovsky E; Freemantle SJ
    BMC Cancer; 2013 Apr; 13():211. PubMed ID: 23621985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational combination of a MEK inhibitor, selumetinib, and the Wnt/calcium pathway modulator, cyclosporin A, in preclinical models of colorectal cancer.
    Spreafico A; Tentler JJ; Pitts TM; Tan AC; Gregory MA; Arcaroli JJ; Klauck PJ; McManus MC; Hansen RJ; Kim J; Micel LN; Selby HM; Newton TP; McPhillips KL; Gustafson DL; Degregori JV; Messersmith WA; Winn RA; Eckhardt SG
    Clin Cancer Res; 2013 Aug; 19(15):4149-62. PubMed ID: 23757356
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monensin inhibits canonical Wnt signaling in human colorectal cancer cells and suppresses tumor growth in multiple intestinal neoplasia mice.
    Tumova L; Pombinho AR; Vojtechova M; Stancikova J; Gradl D; Krausova M; Sloncova E; Horazna M; Kriz V; Machonova O; Jindrich J; Zdrahal Z; Bartunek P; Korinek V
    Mol Cancer Ther; 2014 Apr; 13(4):812-22. PubMed ID: 24552772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the Wnt/b-catenin pathway using PNU-74654 reduces tumor growth in in vitro and in vivo models of colorectal cancer.
    Amerizadeh F; Rahmani F; Maftooh M; Nasiri SN; Hassanian SM; Giovannetti E; Moradi-Marjaneh R; Sabbaghzadeh R; Shahidsales S; Joudi-Mashhad M; Ghayour-Mobarhan M; Ferns GA; Khazaei M; Avan A
    Tissue Cell; 2022 Aug; 77():101853. PubMed ID: 35803035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models.
    Waaler J; Mygland L; Tveita A; Strand MF; Solberg NT; Olsen PA; Aizenshtadt A; Fauskanger M; Lund K; Brinch SA; Lycke M; Dybing E; Nygaard V; Bøe SL; Heintz KM; Hovig E; Hammarström C; Corthay A; Krauss S
    Commun Biol; 2020 Apr; 3(1):196. PubMed ID: 32332858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blockage of PD-L1 by FERMT3-mediated Wnt/β-catenin signalling regulates chemoresistance and immune evasion of colorectal cancer cells.
    Tang Y; Nan N; Gui C; Zhou X; Jiang W; Zhou X
    Clin Exp Pharmacol Physiol; 2022 Sep; 49(9):988-997. PubMed ID: 35672907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
    Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
    Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Wnt addiction of genetically defined cancers reversed by PORCN inhibition.
    Madan B; Ke Z; Harmston N; Ho SY; Frois AO; Alam J; Jeyaraj DA; Pendharkar V; Ghosh K; Virshup IH; Manoharan V; Ong EH; Sangthongpitag K; Hill J; Petretto E; Keller TH; Lee MA; Matter A; Virshup DM
    Oncogene; 2016 Apr; 35(17):2197-207. PubMed ID: 26257057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nigericin Exerts Anticancer Effects on Human Colorectal Cancer Cells by Inhibiting Wnt/β-catenin Signaling Pathway.
    Liu F; Li W; Hua S; Han Y; Xu Z; Wan D; Wang Y; Chen W; Kuang Y; Shi J; Zhi Q
    Mol Cancer Ther; 2018 May; 17(5):952-965. PubMed ID: 29483216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and evaluation of potent Wnt signaling inhibitors featuring a fused 3-ring system.
    Xu Z; Li J; Wu Y; Sun Z; Luo L; Hu Z; He S; Zheng J; Zhang H; Zhang X
    Eur J Med Chem; 2016 Jan; 108():154-165. PubMed ID: 26647303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Discovery and Characterization of K-756, a Novel Wnt/β-Catenin Pathway Inhibitor Targeting Tankyrase.
    Okada-Iwasaki R; Takahashi Y; Watanabe Y; Ishida H; Saito J; Nakai R; Asai A
    Mol Cancer Ther; 2016 Jul; 15(7):1525-34. PubMed ID: 27196752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VALD-3 inhibits proliferation and induces apoptosis of colorectal cancer cells via upregulating tumor suppressor activity of p53 to inhibit Wnt/β-catenin signal pathway.
    Li H; Meng Y; Ma S; Dang C; Xue L
    Anticancer Drugs; 2021 Nov; 32(10):1046-1057. PubMed ID: 34419958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Not All Wnt Activation Is Equal: Ligand-Dependent versus Ligand-Independent Wnt Activation in Colorectal Cancer.
    Kleeman SO; Leedham SJ
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33202731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C644-0303, a small-molecule inhibitor of the Wnt/β-catenin pathway, suppresses colorectal cancer growth.
    Yan Y; Zhang Y; Li M; Zhang Y; Zhang X; Zhang X; Xu Y; Wei W; Wang J; Xu X; Song Q; Zhao C
    Cancer Sci; 2021 Nov; 112(11):4722-4735. PubMed ID: 34431598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models.
    Tam BY; Chiu K; Chung H; Bossard C; Nguyen JD; Creger E; Eastman BW; Mak CC; Ibanez M; Ghias A; Cahiwat J; Do L; Cho S; Nguyen J; Deshmukh V; Stewart J; Chen CW; Barroga C; Dellamary L; Kc SK; Phalen TJ; Hood J; Cha S; Yazici Y
    Cancer Lett; 2020 Mar; 473():186-197. PubMed ID: 31560935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blocking IL-17A enhances tumor response to anti-PD-1 immunotherapy in microsatellite stable colorectal cancer.
    Liu C; Liu R; Wang B; Lian J; Yao Y; Sun H; Zhang C; Fang L; Guan X; Shi J; Han S; Zhan F; Luo S; Yao Y; Zheng T; Zhang Y
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33462141
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.